University of Nebraska - Lincoln

DigitalCommons@University of Nebraska - Lincoln
Vadim Gladyshev Publications

Biochemistry, Department of

2009

The selenoproteome of Clostridium sp. OhILAs: Characterization
of anaerobic bacterial selenoprotein methionine sulfoxide
reductase A
Hwa Young
Yeungnam University, College of Medicine, Daegu 705-717, Republic of Korea

Yan Zhang
University of Nebraska-Lincoln, yzhang3@unl.edu

Byung Cheon Lee
University of Nebraska-Lincoln

Jae-Ryong Kim
Yeungnam University

Vadim N. Gladyshev
University of Nebraska-Lincoln, vgladyshev@rics.bwh.harvard.edu

Follow this and additional works at: https://digitalcommons.unl.edu/biochemgladyshev
Part of the Biochemistry, Biophysics, and Structural Biology Commons

Young, Hwa; Zhang, Yan; Cheon Lee, Byung; Kim, Jae-Ryong; and Gladyshev, Vadim N., "The
selenoproteome of Clostridium sp. OhILAs: Characterization of anaerobic bacterial selenoprotein
methionine sulfoxide reductase A" (2009). Vadim Gladyshev Publications. 85.
https://digitalcommons.unl.edu/biochemgladyshev/85

This Article is brought to you for free and open access by the Biochemistry, Department of at
DigitalCommons@University of Nebraska - Lincoln. It has been accepted for inclusion in Vadim Gladyshev
Publications by an authorized administrator of DigitalCommons@University of Nebraska - Lincoln.

Published in Proteins: Structure, Function, and Bioinformatics 74:4 (2009), pp. 1008-1017; doi 10.1002/prot.22212 Copyright © 2009
Wiley-Liss, Inc., A Wiley Company. Used by permission. http://www3.interscience.wiley.com/journal/36176/home
Research reported in this article was funded by Korea Science and Engineering Foundation (KOSEF); Grant Number: R13-2005005-01004-0; National Institutes of Health (NIH); Grant Number: AG021518; and The Yeungnam University Research Grant.
Submitted May 6, 2008; revised June 18, 2008; accepted June 29, 2008; published online September 2, 2008.

The selenoproteome of Clostridium sp. OhILAs:
Characterization of anaerobic bacterial selenoprotein
methionine sulfoxide reductase A
Hwa-Young Kim, 1 Yan Zhang, 2 Byung Cheon Lee, 2 Jae-Ryong Kim, 1 Vadim N. Gladyshev 2
1Department

of Biochemistry and Molecular Biology, Aging-associated Vascular Disease Research Center, Yeungnam University
College of Medicine, Daegu 705-717, Republic of Korea
2Department of Biochemistry and Redox Biology Center, University of Nebraska, Lincoln, Nebraska 68588
Correspondence — Hwa-Young Kim, Department of Biochemistry and Molecular Biology, Yeungnam University College of Medicine, 317-1 Daemyung-dong, Namgu, Daegu 705-717, South Korea; email hykim@ynu.ac.kr
Abstract
Selenocysteine (Sec) is incorporated into proteins in response to UGA codons. This residue is frequently found at the catalytic sites
of oxidoreductases. In this study, we characterized the selenoproteome of an anaerobic bacterium, Clostridium sp. (also known as
Alkaliphilus oremlandii) OhILA, and identified 13 selenoprotein genes, five of which have not been previously described. One of
the detected selenoproteins was methionine sulfoxide reductase A (MsrA), an antioxidant enzyme that repairs oxidatively damaged methionines in a stereospecific manner. To date, little is known about MsrA from anaerobes. We characterized this selenoprotein MsrA which had a single Sec residue at the catalytic site but no cysteine (Cys) residues in the protein sequence. Its SECIS
(Sec insertion sequence) element did not resemble those in Escherichia coli. Although with low translational efficiency, the expression of the Clostridium selenoprotein msrA gene in E. coli could be demonstrated by 75Se metabolic labeling, immunoblot analyses, and enzyme assays, indicating that its SECIS element was recognized by the E. coli Sec insertion machinery. We found that
the Sec-containing MsrA exhibited at least a 20-fold higher activity than its Cys mutant form, indicating a critical role of Sec in the
catalytic activity of the enzyme. Furthermore, our data revealed that the Clostridium MsrA was inefficiently reducible by thioredoxin, which is a typical reducing agent for MsrA, suggesting the use of alternative electron donors in this anaerobic bacterium
that directly act on the selenenic acid intermediate and do not require resolving Cys residues.
Keywords: MsrA, selenoproteins, oxidoreductase, SECIS elements, thioredoxin
Abbreviations: DTT, dithiothreitol; Msr, methionine sulfoxide reductase; Sec, selenocysteine; SECIS, selenocysteine insertion sequence; Trx, thioredoxin.

immediately downstream of Sec-encoding UGA codons
in bacteria, whereas they are present in the 3′-untranslational regions in archaea and eukaryotes. In addition to
this cis-acting factor, several trans-acting factors, such as
Sec-specific elongation factor and tRNASec, are required
for Sec incorporation.
There has been significant progress recently in identifying selenoprotein genes in organisms from bacteria to
mammals owing to both a dramatic increase in genomic
sequence information and the development of bioinformatics methods that allow searches for selenoprotein genes.[11-16] These methods include searches for
(1) SECIS elements; and (2) Sec/Cys pairs in predicted
homologs.
Methionine residues are easily oxidized by various reactive oxygen species to methionine sulfoxides; however,
the oxidized methionines can be reduced back to methio-

INTRODUCTION
Selenocysteine (Sec) is inserted into proteins when
UGA (normally a stop codon) is recoded to serve as Sec
codon.[1,2] This amino acid is typically found at the catalytic sites of oxidoreductase selenoproteins and is responsible for the high catalytic activity of selenoenzymes
when compared with their cysteine (Cys)-containing homologs.[3-6] Selenoproteins are found in all three domains of life: bacteria, archaea, and eukaryotes. The
glycine reductase A from Clostridium sticklandii was discovered as the first anaerobic selenoprotein.[7,8] A complex machinery is required for translational insertion of
Sec in response to UGA codon.[2,9,10] A stem-loop structure in selenoprotein mRNAs, called SECIS (Sec insertion
sequence) element, is essential for Sec insertion in both
prokaryotes and eukaryotes. SECIS elements are located
1008
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nine by repair enzymes, the methionine sulfoxide reductases (Msrs).[17] Two distinct families of these enzymes,
MsrA and MsrB, have evolved for stereospecific reduction
of methionine sulfoxide residues in proteins. MsrA is specific for the reduction of the S-form of methionine sulfoxide, whereas MsrB is specific for the R-form. Msrs are present in most organisms in all three domains of life (they
have been even found in anaerobic bacteria), but are absent
in some hyperthermophiles and parasites.[18,19] Msrs play
a pivotal role in the repair of oxidatively damaged proteins
and defend cells from oxidative stress. Therefore, these
proteins are viewed as protein repair and antioxidant enzymes.[20-22] These enzymes have been implicated in regulation of physiological and pathological processes such as
aging and neurodegenerative diseases.[23,24]
In this study, we characterized the selenoproteome
of an anaerobic gram-positive bacterium, Clostridium sp.
(also known as Alkaliphilus oremlandii) OhILAs and found
that this bacterium is predicted to be rich in selenoproteins and contains at least 13 selenoproteins, including
MsrA. We further experimentally characterized Clostridium selenoprotein MsrA. We found that its SECIS element
is recognized by the Escherichia coli Sec insertion machinery, and that Sec plays a critical role in the catalytic activity of this selenoprotein.
METHODS
Identification of selenoprotein genes in Clostridium sp.
OhILAs
The complete genome of Clostridium sp. OhILAs (NC_
009922) was downloaded from the NCBI ftp server
(ftp://ftp.ncbi.nih.gov/genomes/Bacteria/). We used
bSECISearch program developed previously[15] to search
this genome for all candidate selenoprotein sequences
containing in-frame UGA codons and bacterial SECIS
(bSECIS) elements. The resulting dataset was then divided into homologs of previously known selenoproteins
and selenoprotein candidates. All candidates were manually analyzed for the location of the UGA codon, occurrence of Sec- and Cys-containing homologs in Sec-utilizing or other organisms, and presence of SECIS elements in
Sec-containing homologs. In parallel, independent BLAST
homology searches for Sec-containing homologs of all
known selenoprotein families were performed using default parameters. Finally, both known and candidate selenoprotein sets were generated. Multiple sequence alignments were performed using ClustalW program[25] with
default parameters and visualized with BoxShade program v3.21.
Cloning, expression, and purification of wild-type selenoprotein and its Cys mutant of Clostridium MsrA
A coding region of the selenoprotein msrA gene was
amplified by PCR using Clostridium sp. OhILAs genomic
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DNA (kindly provided from Dr. John Stolz, Duquesne
University, Pittsburgh, USA) and cloned into NdeI/XhoI
sites of pET21b (Novagen). To amplify the gene, forward
(5′-GCGCCATATGGATACCAATCAGAAGTTG-3′)
and reverse (5′-CGCGCTCGAGTTTAATTTCTTCGACGATAG-3′) primers were used. The resulting construct,
designated pET-CLOS-MsrA, coded for full-length selenoprotein MsrA with a C-terminal His-tag (LEHHHHHH). A SECIS element was found to be located immediately downstream of the Sec UGA codon (see Figure 4). A
Cys mutant form was also generated in which Sec16 was
replaced with Cys by site-directed mutagenesis. The resulting construct was named pET-CLOS-MsrA/U16C.
To express selenoprotein MsrA in E. coli, the plasmid
pET-CLOS-MsrA was transformed into BL21(DE3) cells
that also harbored a plasmid pSUABC,[26] which encodes
E. coli selA, selB, and selC. The transformed cells were
grown in LB media containing 4 μM sodium selenite, 100
μg/mL ampicillin, and 25 μg/mL chloramphenicol at
37°C with shaking until optical density at 600 nm reached
0.6-0.8; then 0.2 mM IPTG was added and the cells were
further cultured for 4 h at 30°C, harvested, and stored at
-20°C until use. A typical expression level of the selenoprotein MsrA was 0.6 μg/mg crude protein.
The cell pellets were resuspended in the extraction buffer (50 mM sodium phosphate, pH 7.0, 300 mM
NaCl, 10 mM imidazole, and 1 mM phenylmethylsulfonyl fluoride) and lysed by sonication. The selenoprotein MsrA was further purified using a Talon-metal affinity resin (Clontech) according to the manufacturer’s
protocol. The eluted proteins were dialyzed against 50
mM sodium phosphate, pH 7.5, and 50 mM NaCl. Typical yield of the purified selenoprotein MsrA was 3-5 μg
from 250 mL culture broth, as estimated by Western blot
assays. Although the protein was not pure, this preparation was sufficient to determine kinetic parameters of
the enzyme.
To express the Cys mutant form (U16C), BL21(DE3)
cells transformed with pET-CLOS-MsrA/U16C were cultivated in LB media containing 100 μg/mL ampicillin at
37°C with shaking until optical density at 600 nm reached
0.6-0.8, 0.1 mM IPTG was added, and the cells were further cultured for 6 h at 30°C. The cells were harvested and
stored at -20°C until use. Procedures for purification of
this protein were as described earlier for the selenoprotein form. The purity of the Cys mutant protein was analyzed by SDS-PAGE and found to exceed 95%.
Metabolic labeling with 75Se
To prepare cells expressing Clostridium selenoprotein
MsrA with metabolically labeled 75Se, E. coli BL21(DE3)
cells were transformed with pET-CLOS-MsrA and grown
at 37°C in 5 mL LB media containing ampicillin until optical density at 600 nm reached ~0.6. Then, 0.05 mCi of
freshly neutralized [75Se]selenous acid (specific activity
1000 Ci/mmol, University of Missouri Research Reactor,
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Table I. Known and New Selenoproteins Detected in Clostridium sp. OhILAs
Protein family

Accession no.

COG/Pfam

Sec position
Occurrence (protein length)

Known selenoproteins

FdhAa
YP_001513778
COG3383
1
YP_001513274
COG0709
1
SelDa
MsrAa
YP_001513481
COG0225
1
Proline reductasea
YP_001511596
pfam07355 (low homology) 1
HesB-like
YP_001511838 (partial sequence)
COG0316
1
YP_001513661
COG0695
1
Glutaredoxina
GrdAa
YP_001512500
pfam04723
1
GrdBa
YP_001512501
pfam07355
1
New selenoprotein candidates
YP_001511765
COG0243
1
Putative anaerobic dehydrogenasea
BFD-like (2Fe-2S)-binding domain protein YP_001512630 (partial sequence)
COG2906 (low homology) 1
Split soret cytochrome c precursora
YP_001512574; YP_001512575
pfam09719 (low homology) 2
				
Predicted NADH:ubiquinone
YP_001511593 (partial sequence)
COG4656
1
oxidoreductase, subunit RnfC
a

349 (891)
16 (346)
16 (209)
151 (241)
32 (95)
13 (76)
44 (158)
350 (435)
257 (1021)
11 (162)
83 (223)
81 (221)
389 (424)

Annotated as selenoproteins in the current genome annotation.

Columbia, USA) was added to the cell culture with 1 mM
IPTG for induction. The cells were further grown at 37°C
for 5 h, harvested, washed with PBS buffer, and lysed.
Cell extracts (40 μg of total protein) were applied to a 10%
Bis-Tris gel (Invitrogen), electrophoresed, and transferred
onto a PVDF membrane. The 75Se radioactivity pattern on
the membrane was visualized by using a PhosphorImager (GE Health Care).
Determination of protein concentration
Concentration of recombinant selenoprotein MsrA was
determined by western blotting using His antibodies and
Cys mutant as an internal standard, followed by quantifying the blot signals with a densitometer. Concentration of purified Cys mutant was determined by Bradford
method using a Bio-Rad protein assay reagent (Bio-Rad)
and bovine serum albumin as a standard.
MsrA enzyme assay and analysis of kinetics
MsrA activity was measured in the presence of dithiothreitol (DTT) or thioredoxin (Trx) as a reducing agent.
In the DTT-dependent reaction, reaction mixture (100
μL) contained 50 mM sodium phosphate, pH 7.5, 50 mM
NaCl, 20 mM DTT, 200 μM DABSyl-methionine-S-sulfoxide, and purified (or crude) proteins. In the Trx-dependent reaction, the reaction mixture (100 μL) contained 50
mM sodium phosphate, pH 7.5, 50 mM NaCl, 0.2 mM
NADPH, 6.8 μM E. coli Trx (Sigma) or human Trx1,[27]
0.8 μM human Trx reductase 1,[27] 200 μM DABSyl-methionine-S-sulfoxide, and purified proteins. The reactions were carried out at 37°C for 30 min and analyzed
by HPLC as described previously.[28] A full-length
mouse MsrA was purified from E. coli as described previously[29] and used for comparison.

Km and kcat values were determined from LineweaverBurk plots using 50-400 μM substrate in the DTT- dependent reaction.
RESULTS AND DISCUSSION
Clostridium sp. OhILAs is a selenoprotein-rich organism
By searching the Clostridium sp. OhILAs genome
against a set of all known selenoprotein genes, we identified eight selenoproteins in Clostridium sp. OhILAs, including formate dehydrogenase alpha subunit (FdhA),
which is the most widespread prokaryotic selenoprotein that appears to be responsible for maintaining the
Sec utilization trait in sequenced bacteria,[30] and selenophosphate synthetase (SelD), another widespread selenoprotein which is a key component in prokaryotic selenoprotein biosynthesis. Other detected selenoproteins
included proline reductase, HesB-like protein, glutaredoxin, glycine reductase selenoproteins A (GrdA) and B
(GrdB), and MsrA. Previously, selenoprotein MsrA has
only been characterized in a eukaryotic organism, Chlamydomonas reinhardtii.[31][32] The selenoproteome of Clostridium sp. OhILAs is shown in Table I and all detected
selenoprotein sequences are included in the supporting
sequence data.
Next, we used bSECISearch to analyze Clostridium sp.
OhILAs for full complement of selenoprotein genes. In
addition to the eight homologs of known selenoproteins,
we detected five new selenoproteins that represented four
protein families (Table I). The mRNAs of all new selenoproteins contained predicted stable stem-loop structures
downstream of Sec-encoding UGA codons that shared
common features of bacterial SECIS elements,[15] i.e. a
stable stem with a small apical loop containing a G nucleotide located at a certain distance from the Sec UGA co-
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Figure 1. Predicted bacterial SECIS elements in new selenoprotein genes. Only sequences downstream of in-frame UGA codons
are shown. In-frame UGA codons and functionally important G nucleotides in the apical loop are shown in red.

don (see Figure 1). No additional common features could
be found in those Clostridium SECIS elements and all of
them were predicted to lack a bulged U which is conserved in E. coli SECIS elements. Selenoprotein homologs of the new selenoproteins were also found in several
other anaerobic bacteria, such as Desulfitobacterium hafniense, Alkaliphilus metalliredigens, and Clostridium botulinum
(see Figure 2). In addition, conserved Cys-containing homologs could be detected for all new selenoproteins in
other organisms. Multiple alignments of new selenoprotein families and their Cys homologs are shown in Figure
2 and highlight conserved Sec/Cys pairs in homologous
sequences that support predicted redox functions of these
proteins.[33]
Although the functions of new selenoproteins are not
clear, they either contained a domain of known function
or were homologous to protein families with known functions. However, in some of them Sec was not part of the
detected domains, suggesting the presence of functional
redox-active sites in the locations outside of known domains. For example, Sec was located in the N-terminal region of BFD-like (2Fe-2S)-binding protein in which the
BFD-like domain (COG2906) was present in the C-terminal region. It was also found in a CxxU (x, any amino acid
residue; U, Sec) redox motif in the C-terminal region of
a predicted NADH:ubiquinone oxidoreductase subunit
RnfC, whereas the known RnfC domain (COG4656) was
located in the N-terminal region. The other three new selenoproteins (putative anaerobic dehydrogenase and two
cytochrome c precursor sequences) were annotated as putative selenoproteins in this genome although the criteria

used in their detection/annotation are not clear. As these
sequences have passed the stringent criteria employed by
bSECISearch in our study, they should be viewed as excellent candidate selenoproteins.
While this study was prepared for publication, the sequences of three new selenoproteins were released at
GenBank database (putative anaerobic dehydrogenase,
158139457; split soret cytochrome c precursor 1, 158320067;
split soret cytochrome c precursor 2, 158320068). It is interesting that the Sec positions differed in the predicted
NADH:ubiquinone oxidoreductase subunit RnfC family between Clostridium sp. OhILAs and several strains of
Clostridium botulinum (see Figure 2). Taken together, our
data suggested that novel Se-dependent pathways are
present in this selenoprotein-rich organism. Further experimental verification is needed for the newly identified
selenoproteins.
Clostridium selenoprotein MsrA sequence
Msr genes have been found in most organisms, even
in anaerobes. The presence of Msr genes in anaerobic bacteria may be due to their roles in protein repair and antioxidant defense when transiently exposed to oxygen. To
date, little is known about such anaerobe-based Msrs. We
selected the anaerobic bacterial selenoprotein MsrA for
further experimental examination. Interestingly, sequence
context revealed lack of any Cys residues in this protein.
Because Sec corresponded to the catalytic residue, this observation suggested the lack of resolving residues during catalysis (see Figure 3). The catalytic mechanism of

1012

H-Y. K i m

et al. in

P r o t e i n s 74 (2009)

Figure 2. Multiple sequence alignments of new selenoproteins and their Cys homologs. The alignments show Sec-flanking regions
in detected selenoproteins. Both selenoprotein sequences detected in Clostridium sp. OhILAs and their Sec/Cys-containing homologs that occur in the indicated organisms are shown. Conserved residues are highlighted. Predicted Sec (U) and the corresponding Cys (C) residues in other homologs are shown in red and blue, respectively.

Cys-containing MsrA is well characterized and involves a
sulfenic acid intermediate.[34-36] During the reaction, the
catalytic Cys attacks the sulfoxide moiety of methionine
sulfoxide resulting in sulfenic acid on this residue with
a concomitant release of the product, methionine. Then,
the sulfenic acid intermediate is rearranged into a disulfide bond by reacting with another Cys, known as resolving (or recycling) Cys, and finally the disulfide bond is reduced by a two-electron reductant. Trx is typically an in
vivo reducing agent while DTT can be used in the in vitro
assays. In the case of Sec-containing forms, the selenenic

acid intermediate may form a selenenylsulfide bond with
a resolving Cys; however, neither of the previously identified selenoprotein MsrAs possesses conserved Cys that
could function as resolving residues.[31] Furthermore, we
previously reported that Chlamydomonas selenoprotein
MsrA does not use resolving Cys.[31]
Expression of Clostridium selenoprotein MsrA in E. coli
The mechanism of Sec insertion has been well elucidated in E. coli.[3,37-39] The SECIS element in mRNA
is essential for Sec insertion and is located immediately
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Figure 3. Multiple sequence alignment of MsrAs. Sec (U) residues are highlighted in red in the catalytic GUFW(G/H) motif and the
corresponding Cys residues are highlighted in blue. The known resolving Cys residues in the C-terminal region are highlighted in
pink. Genbank accession numbers are as follows: Clostridium sp. OhILAs, 106894182; Chlamydomonas reinhardtii, 23452038; Syntrophobacter fumaroxidans, 71547479; E. coli, 1790665; Mus musculus, 31981013; Drosophila melanogaster, 23338220.

downstream of in-frame UGA codons in bacteria. Studies on E. coli SECIS elements revealed that only a minimal
stem-loop is required for Sec insertion in which a GU sequence on the tip of the apical loop and a bulged U present at the bottom of the stem are essential for Sec insertion
(Figure 4, left).[40-42] We recently reported a consensus
bacterial SECIS structural model in which a conserved G
is present in the apical loop, whereas the bulged U is an
E. coli adaptation that is missing in most other bacterial
SECIS elements.[15] Consistent with this consensus, the
SECIS element of Clostridium msrA had a G in the apical
loop, but not the bulged U in the stem (Figure 4, right).
The differences between E. coli SECIS elements and the
corresponding structures in other bacteria result in barriers in heterologous selenoprotein expression.[43]
To test whether Clostridium selenoprotein MsrA can
be expressed in E. coli as recombinant protein, we metabolically labeled cells transformed with Clostridium msrA
gene with 75Se. As shown in Figure 5(A), a 25 kDa radioactive band corresponding in size to the calculated mo-

lecular weight of recombinant Clostridium selenoprotein
MsrA, was detected. We also verified the expression of
this protein by western blot analysis [Figure 5(B)]. In addition, enzyme assays revealed that crude extracts from
cells expressing the Clostridium msrA gene had a 36-fold
increased activity compared with that from cells containing an empty vector [Figure 5(C)]. Thus, these data
showed that Clostridium selenoprotein msrA could be expressed in E. coli, indicating that its SECIS element is recognized by the E. coli Sec insertion machinery. To estimate
the efficiency in Sec insertion (UGA readthrough), we analyzed the amounts of wild-type and Cys mutant (U16C)
forms of the enzyme in crude extracts by Western blotting
using the purified U16C as an internal standard. It should
be noted that most of U16C protein (>95%) expressed in
BL21(DE3) cells was present in the soluble fraction. The
yields of the wild-type selenoprotein and the U16C mutant were 0.6 and 380 μg/mg crude protein, respectively.
Therefore, the translational efficiency of the selenoprotein
MsrA was low, estimated to be 0.15% of that of its Cys
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variant. The activities of the wild-type selenoprotein and
Cys mutant forms in the crude extracts as shown in Figure 5(C) agreed well with those of the purified forms, respectively (Table II).
There have been several reports on heterologous expression of eukaryotic selenoproteins in E. coli.[6,26,44,45]
Either the entire SECIS element of E. coli fdhH (in most
studies) or a minimal SECIS stem-loop had to be introduced downstream of UGA codon to express eukaryotic selenoproteins. In E. coli, heterologous expression of
bacterial selenoproteins that contain their own SECIS elements often fails due to SECIS structure barriers.[46]
However, a few successful cases have been previously reported.[47,48] In our study, irrespective of discrepancies
in Clostridium msrA and E. coli SECIS elements, the Clostridium selenoprotein msrA gene could be expressed in E.
coli. However, as discussed earlier, the translational efficiency was low (less than 0.2% compared with its Cys
variant) even when the cells were co-expressed with
selA, selB, and selC genes encoding selenocysteine synthase, SelB and tRNASec, respectively. These results suggest a low functionality of the SECIS element of Clostridium msrA in the E. coli Sec insertion system.
Characterization of Clostridium selenoprotein MsrA
To investigate catalytic properties of Clostridium MsrA,
we purified this protein (tagged at the C-terminus with
His) from E. coli cells. As shown in Table II, the specific
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Figure 4. Structures of SECIS elements in E. coli fdhH (left)
and Clostridium sp. OhILAs msrA (right). In the E. coli fdhH
SECIS element, the minimal step-loop structure is boxed and
the bulged U is shown in italics. The Clostridium msrA SECIS
element lacks the bulged U. Conserved G in the apical loops
is shown in red in both SECIS elements. Sec UGA codons are
shown in blue.

Figure 5. Expression of Clostridium selenoprotein MsrA in E. coli. (A) 75Se metabolic labeling. BL21(DE3) cells transformed with an
empty vector (lane 1) or pET-CLOS-MsrA (lane 2) were metabolically labeled with 75Se. Proteins were separated by SDS-PAGE,
transferred onto a PVDF membrane, and visualized with a PhosphorImager. (B) Western blot analysis. Purified Cys mutant
(U16C) and crude extracts from cells expressing Clostridium selenoprotein MsrA were analyzed using anti-His antibodies. Lane 1,
purified U16C; lane 2, wild-type selenoprotein MsrA from cell extracts. (C) Enzyme assays. Crude extracts from cells containing
an empty vector, pET-CLOS-MsrA (wild-type), or pET-CLOS-MsrA/U16C (U16C mutant) were prepared, respectively. A total of
200μg crude protein from control and CLOS-MsrA extracts and 2 μg crude protein of the CLOS-MsrA/U16C extract were used in
a DTT-dependent assay in the presence of 200 μM DABSyl-methionine-S-sulfoxide
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Table II. Specific Activity and Kinetic Constants of Clostridium
MsrA Forms
MsrA
form
WT
U16C

Specific
activity [nmol/
(min mg protein)]
4185 ± 46
464 ± 14

Km
(mM)

kcat
(s-1)

10.2 ± 1.2
4.0 ± 0.2

84 ± 5
3.8 ± 0.3
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Table III. Ratios of Trx- to DTT-Dependent Activities
Specific activity
[nmol/(min mg protein)]

kcat/Km
(M-1 s-1)
8235
950

Purified proteins (90 ng WT and 1 μg U16C) were assayed in the DTTdependent reaction. The substrate (DABSyl-methionine-S-sulfoxide)
concentration used was 200 μM for the determination of specific activity. Km and kcat values were determined from Lineweaver-Burk plots
using 50-400 μM substrate in the presence of DTT. WT, wild-type selenoprotein; U16C, Sec to Cys mutant.

activity of Clostridium selenoprotein MsrA was found to
be 4185 nmol/(min mg protein) in a DTT-dependent reaction. This value was 9-fold higher than that of its Cys
mutant (U16C). The kcat value of the selenoprotein MsrA
was 22-fold higher than that of its Cys mutant and the Km
value of the selenoprotein was 2.5-fold higher. Overall,
these data show that selenium provides catalytic advantage to Clostridium MsrA. Importantly, this enzyme appears to be a highly efficient catalyst with kinetic properties comparable with those of Chlamydomonas MsrA
characterized previously.[31]
Trx is typically a natural reductant for MsrA. To test if
Trx can function as a reductant for Clostridium MsrA, we
measured Trx-dependent activities of its natural Sec-containing and mutant Cys-containing forms using human
Trx1 and Trx reductase 1, and compared the data with the
DTT-dependent activities of these MsrA forms. In addition, mouse MsrA served as control because this protein is
known as a target of Trx. As shown in Table III, the ratio
of Trx- to DTT-dependent activities of mouse MsrA was
0.73, indicating that human Trx1 as well as DTT could efficiently reduce this protein. However, for Clostridium
selenoprotein MsrA, this ratio was less than 0.01, suggesting that Trx1 was a poor reductant for this selenoprotein.
Similarly, the Cys mutant could not be efficiently reduced
by Trx1 (the ratio of Trx- to DTT-dependent activity was
0.03). To examine the possibility that human Trx couples
poorly to the bacterial selenoprotein MsrA, we carried out
the enzyme assay in the presence of bacterial (E. coli) Trx.
The ratios of Trx- to DTT-dependent activities were consistent with the results for human Trx1; 0.93 for mouse
MsrA, 0.016 for Clostridium selenoprotein MsrA, and 0.05
for its Cys mutant. Therefore, our data suggested that Trx
is not a reducing agent in vivo for Clostridium MsrA and
that unknown physiological reductant(s) must function in
the reduction of this enzyme.
Recent studies revealed that thionein (a low-molecular-mass Cys-rich protein) can function as a reducing
agent for MsrA and MsrB,[49] and that selenium com-

MsrA form

DTT-dependent
reaction

WT
U16C
Mouse MsrA

4185 ± 46
464 ± 14
256 ± 24

Trx-dependent
reaction
hTrx1

eTrx

34 ± 5
14 ± 2
188 ± 9

70 ± 6
23 ± 2
238 ± 8

Ratio of
Trx/DTT
activity
hTrx1

eTrx

0.008
0.03
0.73

0.017
0.05
0.93

Purified proteins (90 ng WT, 1 μg U16C, and 1 μg mouse MsrA) were
used in the DTT- and Trx-dependent assays containing 200 μM DABSyl-methionine-S-sulfoxide. hTrx1, human cytosolic Trx; eTrx, E. coli
Trx; WT, Clostridium selenoprotein MsrA; U16C, its Cys mutant.

pounds such as selenocysteamine could reduce mammalian MsrBs.[50] Our previous study on Chlamydomonas selenoprotein MsrA and its Cys mutant revealed that
the Trx-dependent activities of these enzyme forms were
more than 20-fold lower than their DTT-dependent activities.[31] Taken together and combined with the observation that known selenoprotein MsrAs lack conserved
resolving Cys residues (or do not have any Cys as in Clostridium MsrA),[31] our data on Chlamydomonas and Clostridium MsrAs suggest that Trx is not a natural reducing
agent for the selenenic acid intermediates of selenoprotein MsrAs.
CONCLUSIONS
This study shows that Clostridium sp. OhILAs, a grampositive anaerobic bacterium, is predicted to be a selenoprotein-rich organism that contains 13 selenoproteins,
including five that have not been previously described. Interestingly, one of the detected selenoproteins was MsrA,
which serves an antioxidant function by catalyzing the reduction of methionine-S-sulfoxide. Little is known about
anaerobic bacterial MsrAs. We cloned and expressed this
Clostridium selenoprotein in E. coli. Although its SECIS element did not resemble those in E. coli, we could verify
the recombinant protein expression by 75Se labeling, western blots, and activity assays. Thus, the SECIS element
of Clostridium selenoprotein msrA is functional and recognized by the E. coli Sec insertion machinery, although
the translational efficiency was found to be low. The enzyme assays and kinetic analyses revealed that the selenoprotein MsrA is much more active than its Cys mutant
form, indicating a key contribution of selenium to the catalytic efficiency of this selenoenzyme. Our data also suggest that Trx, a general in vivo reducing agent for MsrA, is
not a reductant for Clostridium selenoprotein MsrA. Further studies will be needed to characterize the detailed reductase steps including determination of the natural reducing agent for this selenoprotein MsrA.
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Supplementary Sequence Data
>FdhA
MAKIMINGESYEVKNDITILQACREIGIEIPTLCHDDRLEPHAACRLCIVEIEGVRNLSTSCTMKVAEGM
NIQTHSKNVMNTRKELLDLLFSNHPNDCLTCEKSGECKLQDYCYEYGVLGGSYKGEKRNLPIDYSNHFYT
YDPNKCILCGKCVRVCSELQCTNAITIDERGFHTSIATPFRKGLEHSTCVSCGNCVAVCPVGALTPKKRQ
KVRAWETKKVKTTCSYCGVGCQLNLIVHEDKVIGAEPGRGVPNDGLLCVKGRFANAFINHEERLKTPLIR
KNGVLEEATWDEALGLIVSKVQSTKEKHGANALGGFSSARCTNEENYLFQKLFRAVIGTNNVDHCARLUH
SATVAGLATTLGSGAMTNSIGEVVNNDLLFITGTNTTENHPVIGTQVKQAKKKGAKLIVADPRRIELADM
ADVYLQIKPGTNIALMNGMLNYIIENDLHDKAYIEERTENFEDVKETVKAYTLERTAQICGVAPEDIAKA
ARMYAASDRAGIYYAMGITQHTTGTHNVISVSNLALACGNIGKEFAGVNPLRGQNNVQGACDMGALPSDY
PGYQKVFKPEIAEKFEAAWNAKLSREVGLTVSEMIQKAETGDLKFLYIMGENPMVSDPDINHVKHSLENI
DFLVVQDIFLTETAELADIVLPAASFAEKDGTFVNTERRVQRVRQAIPPVGGAKADWVILMELMNRLGYS
KTYGHPSEIMEEIAMVTPQYGGISYERIEKVGIQWPCPTADHPGTKYLHKAAIARGRGLFYPVEHTGSVE
TKDREYPFILTTGRILYHYHTRTMTGREEGLNKIVPNSYIEVNDITANKLDLEDGEVVKVSSRRGSIKVA
VKVTDIVDEDVVFIPFHFAQGAANYLTNAQHDPISKIPELKVAAVKLEKIV
>SelD
MNQNRRLTQMTKSAGUAAKLGPDVLAQVLCDLPKIEDPNLIVGLETSDDAAVYKINDDMALIQTLDFFTP
VVDDPYTYGQIAAANSLSDVYAMGGRPLTAMNIVCFPNCLDPKILNQILKGGADKVLESGALLVGGHTVE
DDEPKYGLSITGIVHPKKVWANSTAREGDYLILTKPVGLGVLNTAIKADIATKEQYDGAVKVMSMLNKYA
FEALENLDVSACTDITGFGFLGHVYEMAKGSGVSIEIFADKVPLIDGAKELATMGIIPAGMYSNKKHIEN
EVLKEQDIEDAIEDLLYDPQTSGGLLVSISEKDLPDALENLSLIESNGFSVVGRVLPRSDYAVYVK
>GrdA
MARFDGKKIIIIGDRDGIPGPAIEECLKGTGAEVVFSATECFVUTAAGAMDLENQQRVKDLTEKYGADNV
VVVLGAAEAEASGLAAETVTAGDPTFAGPLAGVQLGLRVYHAVEPQFKDEVDAGVYDDQVGMMEMVLDVD
SIVEEMNNIRSEFSKYND
>GrdB
MSKKRVVHYINQFFAGIGGEEKADIRPELREGVVGPGMALNTAMNEEAEIVATIICGDSYFNENLEEAKN
EIIEMVKKYNPDLFIAGPAFNAGRYGVACGTIAKAVNDELEIPVLTGMYIENPGADMFKKNIYIVETGNS
AAAMRKAVPAMASLAAKLLKGEAIGTPKEDQYIPRGIRKNYFSEEKGATRAVNMLMKKLKGEEFTTEYPM
PDFDRVDPNPAVQDLSKIKIAIVTSGGIVPKGNPERIESSSASKYGKYDISSFDDLTEADHETAHGGYDP
VYANIDPDRVIPVDVLRDMEKEGVIGELHKYFYTTVGNGTSVGNSKKFAEEFAKELIADGVQAVILTSTU
GTCTRCGATMVKEIERAGIPVVHMCTVVPISLTVGANRIVPTVAIPHPLGNPNLEPKEEKALRRKLVEKA
LEALTTEVAGQTVFE
>Proline reductase
MSLSIVKGLQSEIFVPITPPPVWTPVKKELKDMTIALATAAGVHLKSDKRFNLAGDFSFREVPVESLSTD
LMVSHGGYDNGDVNKDINCMFPIDRLKELAEEGFIKAAAPVHFGFMGGGGDQQKFQEETGPEIARRLKSE
GVDAVLLTAGUGTCHRSAVIVQRAIEESGIPTIIIAALPPVVRQNGTPRAVAPLVPMGANAGAPNDKAMQ
TAIVRDSLIQLVEITSAGKIVQLPYEYTAKV
>HesB-like
MKINLTESAKQEILKQNTKDRGVRIYVASMGUSGPSFSLSLEEATQHDVVKDVNGVKFVIDKMLDNRFDE
VKVDYGTVMFRKGFIVALENGGGGC
>MsrA
MDTNQKLSIAVFALGUFWGPDAQFGSIKGVVSTRVGYAGGTTNNPSYYNLGDHSESIEIQYDANVITYGE
LLNIFWNLHNPVYETTNRQYMSRIFYLDDGQKSEALEMKRQIEAANGEKIYTEIVPLENFYLAEGYHQKY
YLQNTTKLYQTLKAIYGGFGNLVRSTLAARMNGYIAGNLSIASLKEEMDLVELPEDQYEKVLSIVEEIK
>Glutaredoxin
MAKEVIVYTSNTUPHCFTVKEFLSENNVEFTEKNIQTDAAARKELMKKGIMAVPVIQIDEEVVVGFDRDK
IEELLG

1

#New
>putative anaerobic dehydrogenase
MKRRTFLKLSALTVGASALGLGITGCNKETDVSIDGFPEMPQTLGQGVEATVDPKSGEVKVNSDILVKSS
VCMGCYSSCGVRAKIDKQTGRIMKLTGNPYHPKCAEPALPYDTTIKESYQAFSLYGDQGHTHRATVCARG
NAAFEQVYDPMRITTPMKRAGERGSGKWKPISWEQLIEETVEGGKIFADLGDNTVVEGFRKVYSQDELIN
PDAPEMGPKSNGLVWISGGSYGRINFAQRFVLNSFGSTNFYGHTGTUGGAWRPAWQVLYDNGAGGVYKPD
LQDAEFCLYQGAYPGHSGMSFQTLARKTVKGVMENKLKLAVIDPFMQGGTDIPGKTKWIPIKPSTDGALV
LGMMRYIFDNEKFDGKFLECSNEEAAKAIGFKSYTNATHLVIVDEKHPNNRRFLKPEDLGLEGEGFFVID
KKTGKPELHSKASAGNLLYSGEIQGKTGTIKVATSLYLLKQGIERHSLEEYAEICGIPAKQIEELAKEFT
SHGHKVAVDTLGGTNSVNSLPFTVALWILPALMGAYNMKGGMAGNGPSFKAFADGPKYDLAAFEGQIKPS
GVKISREQFPYEKTTEYKNKVAQGKKPYPSKLPWHTNGMSLDGQAMFSALNKYPYQCKILVNCFANPLYG
TPSLYQETMLEELKKTSNIPLIISVDIVMGETTAYADYIVPDTSVYEQWAMVPVRANINTKMTAIRYPMI
EPMTPKVGSSNQPISMETYLIEVAKKIGMPGFGDNAIKDADGKLWPLNTREDYFIKAIANMAYDGEAVSS
ITEEDDKITGLDSIPSDWQAAIKPDELFVVKNVIAKGGRFEADTNYHDGQFMKYGDLVKVCFYSENLANS
RNSITGAYNEGSPVWAPETLADGTLVDQAYPSEEYPFRVCSSKAKLRGVSMLNNCPTLQVLSDTNYIEIN
ALDAKDFGLKDGQEVMVETPSNKAKGVLKVREGVARGSLGISFGYGKWEYGSKDTTIDGKVVKGESIRAV
GIASNPLALIDHSVKGKYGLSEVTSGTHNRNGIRAKIVPLS
>BFD-like (2Fe-2S)-binding domain protein
MEENIMNRNCUGSQANSTSLVEENKFCPICNEEGIQVKGITVKHMVIENLIPQVEDDNYYLCLSEKCDIV
YYSSNSDFHIEKEQIKVPIWFKEDANPKYICYCNRVTEENIVNAIRNEGARNIKDIIKLTGAMKNGKCEI
NHPTGKCCSPIIQETIDRALGI
>Split soret cytochrome c precursor 1
MAMEEKKQMTRKDFLKKAGMSVAGVAMAGGVGGILTACTNSGTASVNSTGTPDKPQWPFKYVKIDPAKAE
ARAYTGYKEKGGUGAGVAEGFFGTLADEAGYPFNQIPAEAFTAAAGGYGQATLCGSLGVAAACIGMVTDV
DTQKKIVGELFKWYKTAEFPQYQPEGLGLKHTVAESILCEDSVGTFMKEQGVAYGDPERKARCAGTAADV
TRKMVELLNETLA
>Split soret cytochrome c precursor 2
MDVKKSITRKDFLKRAGMSAAGIAMAGGVGGILTACTNAGTASVNSTGTPDKPQWPFKYVKLDPAKVEER
AFKGYKEKGGUGVGVAEGFFGTLADEVGYPFNQIPTEGFTAAAGGYGMATLCGSLGVAAACIGMVTDVDT
QKKIVADLYKWYKTFEFPQYQPEGLGLKHTVAESVLCEDSVGKFMKEQGVAYGDPERKSRCAGVTADVTR
KMVELLNEALA
>COG4656: Predicted NADH:ubiquinone oxidoreductase, subunit RnfC
MLIKISLKQHVGVESKAIVKENEKVKKGQLLAVPDGLGSNIHSSVHGIIEKVTSEYVSIKAYSDQSEDYM
MIKATDNYLEAIKEAGVVGAGGAGFPTHIKLDVDLTGGYVIVNAAECEPVLNHNMLAIEKQPDLILRGLK
YVMEITKAAKGYIAIKPKNKNAIIALGKVCKSESNIEIKFLPDMYPAGDERVIVRELLNVELKPGKLPIE
VNTVVLNIETIKNICLAIEKRKPVITKDITVGGRVKAPKVFLESPIGYPVSYFIDQCGGYENPHGEIVIG
GPFTGKKGGEETTIIKTTGGILVAMPFPVEKRKVGIIACECGAQEERLKEIAAGMEAEVVAEVQCKRMTA
FNGRYRCDLPGVCPGQAEKVLFLKKQGAEVIITGTCEDUTNTVMMTAPRLGVPVYHSTDHVLRGSNHKLY
RKKQ
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